| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.974 | 0.004 | 0.988 | Analgesic | 0.973 0.004 CID_13728875 0.988 0.003 CID_4253 | CID_4253 | |
| 0.963 | 0.002 | 0.97 | Psychostimulant | 0.915 0.003 CID_13728875 0.97 0.002 CID_4253 | CID_4253 | |
| 0.921 | 0.002 | 0.975 | Analgesic, opioid | 0.895 0.002 CID_13728875 0.975 0.001 CID_4253 | CID_4253 | |
| 0.914 | 0.001 | 0.914 | Anesthetic general | 0.836 0.002 CID_13728875 0.881 0.002 CID_4253 | ||
| 0.894 | 0.003 | 0.894 | Spasmolytic | 0.815 0.004 CID_13728875 0.858 0.004 CID_4253 | ||
| 0.828 | 0.002 | 0.87 | Opioid antagonist | 0.807 0.002 CID_13728875 0.87 0.001 CID_4253 | CID_4253 | |
| 0.802 | 0.002 | 0.858 | Opioid mu receptor antagonist | 0.78 0.002 CID_13728875 0.858 0.001 CID_4253 | CID_4253 | |
| 0.793 | 0.002 | 0.877 | Opioid agonist | 0.769 0.002 CID_13728875 0.877 0.002 CID_4253 | CID_4253 | |
| 0.775 | 0.004 | 0.775 | 5 Hydroxytryptamine release stimulant | 0.65 0.01 CID_13728875 0.733 0.005 CID_4253 | ||
| 0.758 | 0.002 | 0.798 | Opioid delta receptor antagonist | 0.742 0.002 CID_13728875 0.798 0.001 CID_4253 | CID_4253 | |
| 0.754 | 0.002 | 0.857 | Opioid mu receptor agonist | 0.718 0.002 CID_13728875 0.857 0.001 CID_4253 | CID_4253 | |
| 0.734 | 0.002 | 0.778 | Opioid kappa receptor antagonist | 0.702 0.002 CID_13728875 0.778 0.001 CID_4253 | CID_4253 | |
| 0.664 | 0.002 | 0.77 | Opioid delta receptor agonist | 0.622 0.002 CID_13728875 0.77 0.002 CID_4253 | CID_4253 | |
| 0.624 | 0.028 | 0.624 | Transcription factor NF kappa B inhibitor | 0.592 0.032 CID_13728875 0.622 0.029 CID_4253 | ||
| 0.57 | 0.004 | 0.725 | Sigma receptor antagonist | 0.505 0.004 CID_13728875 0.725 0.003 CID_4253 | CID_4253 | |
| 0.555 | 0.002 | 0.659 | Opioid kappa receptor agonist | 0.493 0.002 CID_13728875 0.659 0.001 CID_4253 | CID_4253 | |
| 0.53 | 0.004 | 0.618 | Alpha 2 adrenoreceptor antagonist | 0.505 0.004 CID_13728875 0.618 0.004 CID_4253 | CID_4253 | |
| 0.494 | 0.01 | 0.553 | Sigma receptor agonist | 0.119 0.116 CID_13728875 0.553 0.005 CID_4253 | CID_4253 | |
| 0.46 | 0.004 | 0.698 | Alpha 2a adrenoreceptor antagonist | 0.452 0.004 CID_13728875 0.698 0.003 CID_4253 | CID_4253 | |
| 0.46 | 0.044 | 0.493 | Immunosuppressant | 0.493 0.035 CID_13728875 0.491 0.036 CID_4253 | CID_13728875 | |
| 0.419 | 0.005 | 0.419 | Expectorant | 0.364 0.005 CID_13728875 0.351 0.006 CID_4253 | ||
| 0.402 | 0.016 | 0.402 | P-glycoprotein inhibitor | 0.317 0.026 CID_13728875 0.382 0.018 CID_4253 | ||
| 0.428 | 0.122 | 0.486 | Antiinflammatory | 0.409 0.134 CID_13728875 0.486 0.093 CID_4253 | CID_4253 | |
| 0.369 | 0.066 | 0.369 | Vasodilator, peripheral | 0.201 0.174 CID_13728875 0.257 0.122 CID_4253 | ||
| 0.317 | 0.014 | 0.317 | Alpha adrenoreceptor antagonist | 0.252 0.02 CID_13728875 0.277 0.017 CID_4253 | ||
| 0.347 | 0.046 | 0.417 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.082 CID_13728875 0.417 0.026 CID_4253 | CID_4253 | |
| 0.321 | 0.046 | 0.321 | Tumour necrosis factor alpha release inhibitor | 0.274 0.064 CID_13728875 0.217 0.095 CID_4253 | ||
| 0.291 | 0.016 | 0.356 | Antipruritic | 0.27 0.019 CID_13728875 0.356 0.009 CID_4253 | CID_4253 | |
| 0.284 | 0.017 | 0.319 | Interleukin 6 antagonist | 0.222 0.03 CID_13728875 0.319 0.013 CID_4253 | CID_4253 | |
| 0.268 | 0.004 | 0.327 | Toll-Like receptor 4 antagonist | 0.256 0.004 CID_13728875 0.327 0.003 CID_4253 | CID_4253 | |
| 0.284 | 0.044 | 0.323 | Nitric oxide antagonist | 0.258 0.049 CID_13728875 0.323 0.036 CID_4253 | CID_4253 | |
| 0.246 | 0.016 | 0.283 | Toll-Like receptor antagonist | 0.21 0.027 CID_13728875 0.283 0.009 CID_4253 | CID_4253 | |
| 0.352 | 0.138 | 0.388 | Apoptosis agonist | 0.311 0.164 CID_13728875 0.388 0.12 CID_4253 | CID_4253 | |
| 0.225 | 0.032 | 0.302 | Acetylcholine M1 receptor antagonist | 0.149 0.076 CID_13728875 0.302 0.014 CID_4253 | CID_4253 | |
| 0.22 | 0.038 | 0.225 | Cholinergic | 0.225 0.036 CID_13728875 0.212 0.041 CID_4253 | CID_13728875 | |
| 0.188 | 0.035 | 0.23 | Cholinergic antagonist | 0.145 0.055 CID_13728875 0.23 0.025 CID_4253 | CID_4253 | |
| 0.171 | 0.022 | 0.187 | Antineoplastic alkaloid | 0.144 0.029 CID_13728875 0.187 0.017 CID_4253 | CID_4253 | |
| 0.205 | 0.062 | 0.207 | Hepatoprotectant | 0.181 0.079 CID_13728875 0.207 0.061 CID_4253 | CID_4253 | |
| 0.252 | 0.111 | 0.272 | Caspase 3 stimulant | 0.205 0.162 CID_13728875 0.272 0.095 CID_4253 | CID_4253 | |
| 0.151 | 0.015 | 0.214 | Dopamine agonist | 0.128 0.018 CID_13728875 0.214 0.009 CID_4253 | CID_4253 | |
| 0.166 | 0.032 | 0.166 | Antiadrenergic | 0.166 0.032 CID_13728875 0.148 0.036 CID_4253 | ||
| 0.173 | 0.039 | 0.217 | Acetylcholine antagonist | 0.134 0.06 CID_13728875 0.217 0.027 CID_4253 | CID_4253 | |
| 0.231 | 0.103 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.25 0.08 CID_13728875 0.288 0.052 CID_4253 | CID_4253 | |
| 0.134 | 0.007 | 0.182 | Dopamine D2 agonist | 0.05 0.027 CID_13728875 0.182 0.005 CID_4253 | CID_4253 | |
| 0.173 | 0.054 | 0.213 | Protein kinase stimulant | 0.167 0.057 CID_13728875 0.213 0.037 CID_4253 | CID_4253 | |
| 0.141 | 0.026 | 0.202 | Prolactin inhibitor | 0.12 0.038 CID_13728875 0.202 0.008 CID_4253 | CID_4253 | |
| 0.119 | 0.003 | 0.132 | Prolactin release inhibitor | 0.092 0.005 CID_13728875 0.132 0.003 CID_4253 | CID_4253 | |
| 0.149 | 0.035 | 0.15 | Adrenaline antagonist | 0.15 0.034 CID_13728875 0.129 0.041 CID_4253 | CID_13728875 | |
| 0.16 | 0.049 | 0.16 | Acetylcholinesterase inhibitor | 0.116 0.081 CID_13728875 0.155 0.052 CID_4253 | ||
| 0.246 | 0.139 | 0.246 | Vasodilator, coronary | 0.239 0.145 CID_13728875 | ||
| 0.211 | 0.107 | 0.28 | Antioxidant | 0.242 0.088 CID_13728875 0.28 0.07 CID_4253 | CID_4253 | |
| 0.127 | 0.028 | 0.144 | Acetylcholine nicotinic antagonist | 0.107 0.035 CID_13728875 0.144 0.022 CID_4253 | CID_4253 | |
| 0.115 | 0.029 | 0.117 | Alpha 2d adrenoreceptor antagonist | 0.112 0.031 CID_13728875 0.117 0.026 CID_4253 | CID_4253 | |
| 0.144 | 0.059 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.137 0.087 CID_13728875 0.142 0.065 CID_4253 | ||
| 0.135 | 0.054 | 0.165 | Acetylcholine muscarinic antagonist | 0.165 0.036 CID_4253 | CID_4253 | |
| 0.108 | 0.03 | 0.164 | Dopamine D2 antagonist | 0.057 0.052 CID_13728875 0.164 0.021 CID_4253 | CID_4253 | |
| 0.109 | 0.035 | 0.157 | Dopamine antagonist | 0.157 0.024 CID_4253 | CID_4253 | |
| 0.119 | 0.05 | 0.131 | Alpha 2c adrenoreceptor antagonist | 0.09 0.076 CID_13728875 0.131 0.042 CID_4253 | CID_4253 | |
| 0.102 | 0.037 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 CID_13728875 0.098 0.042 CID_4253 | CID_13728875 | |
| 0.182 | 0.12 | 0.182 | Vasodilator | 0.182 0.12 CID_13728875 | ||
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | 0.146 0.111 CID_13728875 0.155 0.098 CID_4253 | ||
| 0.102 | 0.044 | 0.102 | Acetylcholine M3 receptor agonist | 0.1 0.045 CID_13728875 | ||
| 0.103 | 0.045 | 0.138 | Antineoplastic antibiotic | 0.103 0.045 CID_13728875 0.138 0.034 CID_4253 | CID_4253 | |
| 0.121 | 0.066 | 0.121 | Anesthetic local | |||
| 0.069 | 0.015 | 0.123 | Dopamine D5 antagonist | 0.05 0.025 CID_13728875 0.123 0.008 CID_4253 | CID_4253 | |
| 0.18 | 0.128 | 0.183 | Peptidyltransferase inhibitor | 0.181 0.127 CID_13728875 0.183 0.123 CID_4253 | CID_4253 | |
| 0.111 | 0.061 | 0.115 | Electron transport complex I inhibitor | 0.101 0.08 CID_13728875 0.115 0.054 CID_4253 | CID_4253 | |
| 0.08 | 0.036 | 0.1 | Neuronal nicotinic receptor antagonist | 0.07 0.045 CID_13728875 0.1 0.024 CID_4253 | CID_4253 | |
| 0.112 | 0.07 | 0.115 | Estrogen antagonist | 0.113 0.068 CID_13728875 0.115 0.064 CID_4253 | CID_4253 | |
| 0.223 | 0.181 | 0.248 | Calcium channel activator | 0.248 0.15 CID_13728875 | CID_13728875 | |
| 0.163 | 0.128 | 0.163 | Aldehyde oxidase inhibitor | |||
| 0.1 | 0.065 | 0.104 | Estrogen receptor beta antagonist | 0.096 0.071 CID_13728875 0.104 0.057 CID_4253 | CID_4253 | |
| 0.049 | 0.015 | 0.097 | Nociceptin (N/OFQ) receptor antagonist | 0.035 0.025 CID_13728875 0.097 0.006 CID_4253 | CID_4253 | |
| 0.169 | 0.14 | 0.195 | Immunostimulant | 0.195 0.123 CID_4253 | CID_4253 | |
| 0.031 | 0.004 | 0.038 | NMDA receptor phencyclidine site antagonist | 0.038 0.004 CID_13728875 0.03 0.004 CID_4253 | CID_13728875 | |
| 0.214 | 0.187 | 0.214 | Histamine release inhibitor | |||
| 0.03 | 0.009 | 0.052 | Dopamine D1 agonist | 0.052 0.004 CID_13728875 0.051 0.005 CID_4253 | CID_13728875 | |
| 0.092 | 0.077 | 0.092 | Nav1.1 sodium channel blocker | 0.088 0.083 CID_4253 | ||
| 0.166 | 0.153 | 0.166 | Hypoglycemic | |||
| 0.048 | 0.037 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 CID_13728875 0.054 0.027 CID_4253 | CID_13728875 | |
| 0.068 | 0.06 | 0.089 | Glycine receptor agonist | 0.074 0.047 CID_13728875 0.089 0.028 CID_4253 | CID_4253 | |
| 0.107 | 0.1 | 0.107 | Nav1.2 sodium channel blocker | |||
| 0.082 | 0.077 | 0.098 | Breast cancer-resistant protein inhibitor | 0.089 0.067 CID_13728875 0.098 0.057 CID_4253 | CID_4253 | |
| 0.052 | 0.047 | 0.053 | Dopamine uptake inhibitor | 0.053 0.046 CID_4253 | CID_4253 | |
| 0.057 | 0.054 | 0.139 | Dopamine D1 antagonist | 0.139 0.016 CID_4253 | CID_4253 | |
| 0.048 | 0.046 | 0.048 | Acetylcholine M2 receptor agonist | |||
| 0.192 | 0.199 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 CID_4253 | CID_4253 | |
| 0.097 | 0.108 | 0.131 | Cyclooxygenase 3 inhibitor | 0.131 0.066 CID_13728875 | CID_13728875 | |
| 0.013 | 0.025 | 0.029 | Nociceptin (N/OFQ) receptor agonist | 0.029 0.01 CID_4253 | CID_4253 | |
| 0.027 | 0.044 | 0.05 | Nicotinic receptor beta4 subunit antagonist | 0.05 0.016 CID_13728875 0.033 0.031 CID_4253 | CID_13728875 | |
| 0.086 | 0.107 | 0.125 | MAO inhibitor | 0.125 0.072 CID_4253 | CID_4253 | |
| 0.11 | 0.137 | 0.135 | NOS3 expression enhancer | 0.135 0.09 CID_4253 | CID_4253 | |
| 0.168 | 0.204 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.182 0.171 CID_13728875 0.2 0.136 CID_4253 | CID_4253 | |
| 0.074 | 0.111 | 0.088 | Anabolic | 0.088 0.083 CID_4253 | CID_4253 | |
| 0.039 | 0.079 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 CID_4253 | CID_4253 | |
| 0.077 | 0.123 | 0.118 | Cholesterol synthesis inhibitor | 0.118 0.067 CID_13728875 | CID_13728875 | |
| 0.119 | 0.193 | 0.196 | Free radical scavenger | 0.196 0.101 CID_4253 | CID_4253 | |
| 0.058 | 0.138 | 0.097 | Creatine kinase inhibitor | 0.097 0.062 CID_4253 | CID_4253 | |
| 0.063 | 0.15 | 0.123 | Adenylate cyclase inhibitor | 0.123 0.065 CID_4253 | CID_4253 | |
| 0.048 | 0.141 | 0.075 | Glycine receptor antagonist | 0.075 0.065 CID_4253 | CID_4253 | |
| 0.073 | 0.168 | 0.114 | Lipid peroxidase inhibitor | 0.114 0.1 CID_4253 | CID_4253 | |
| 0.121 | 0.224 | 0.165 | DNA damaging | 0.165 0.151 CID_4253 | CID_4253 | |
| 0.086 | 0.209 | 0.143 | Insulin secretagoues | 0.143 0.082 CID_13728875 | CID_13728875 | |
| 0.009 | 0.138 | 0.039 | 5 Hydroxytryptamine 2C agonist | 0.039 0.038 CID_13728875 | CID_13728875 | |
| 0.05 | 0.186 | 0.106 | Cystathionine beta-synthase inhibitor | 0.106 0.07 CID_4253 | CID_4253 | |
| 0.087 | 0.226 | 0.13 | Adenylate cyclase stimulant | 0.13 0.101 CID_13728875 | CID_13728875 | |
| 0.087 | 0.231 | 0.138 | Melanin inhibitor | 0.138 0.1 CID_4253 | CID_4253 | |
| 0.013 | 0.165 | 0.05 | Dopamine D5 agonist | 0.05 0.017 CID_13728875 | CID_13728875 | |
| 0.059 | 0.216 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.067 CID_4253 | CID_4253 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |